Results 181 to 190 of about 20,576 (195)

Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial

Lancet Oncology, The, 2013
Vladimir Borisovich Matveev, Tony Elliott, Daniel P Petrylak   +2 more
exaly  

Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study

Annals of Oncology, 2016
Gunnar Folprecht, Arndt Vogel
exaly  

Phase 1–2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer

Lancet Oncology, The, 2011
Robert L Coleman, John V Heymach, Edward F Jackson   +2 more
exaly  

Intravitreal Aflibercept for Diabetic Macular Edema

Ophthalmology, 2016
Jean-François Korobelnik, Ursula M Schmidt-Erfurth, Edoardo Midena   +2 more
exaly  

Aflibercept

Reactions Weekly, 2014
openaire   +2 more sources

Intravitreal Aflibercept Injection for Macular Edema Due to Central Retinal Vein Occlusion

Ophthalmology, 2014
Jeffrey S Heier, David S Boyer, Julia A Haller   +2 more
exaly  

Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial

European Journal of Cancer, 2014
Josep Tabernero Caturla, Vladimir M Moiseyenko   +1 more
exaly  

Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration

Ophthalmology, 2012
Jeffrey S Heier, Ngaihang Victor Chong, Jean-François Korobelnik   +2 more
exaly  

Aflibercept

Nature Reviews Drug Discovery, 2012
exaly  

Ziv-aflibercept: binding to more than VEGF-A—does more matter?

Nature Reviews Clinical Oncology, 2012
exaly